Zeus Report SACHIN K P

An Organization study On Zeus Biotech Private Limited, Mysuru
CHAPTER -1
INTRODUCTION ABOUT THE INDUSTRY
Industry profile:
Growth in milk sector has occurred mainly through co-operative efforts. The milk
collection centers started through co-operative effort and collected milk from villagers in
quantities as small as liter and gradually started to provide other services to farmers,
including education, artificial insemination, veterinary health support and feeding. Small
farmers became prosperous, loan facilities were made available through banks, and member
farmers started to share the profits from co-operatives. Co-operative society also set up their
own computerized feed plant. They began to own modern computerized as well-equipped
milk processing plants from which they produce and market pasteurized milk, butter oil,
chocolate, ice-cream from milk, sweets, which are very popular with Indian consumers.
Today the feed production capacity of the co-operative society is about 0.7million tones per
year.
1.1 The future of the Indian feed industry
Feed industry in India is about 50 years old. It primarily consists of cattle feed
and poultry feed segments. Cattle feed industry in India is gradually evolving into an
organized sector and the feed manufactures are increasingly using modern and sophisticated
methods that seek to incorporate best global practices. Indian cattle feed industry has got high
growth potential, given the country’s top position among the world nations in respect of
livestock population and also the high expected growth rate of about 4 per cent.
At the beginning of the twenty-first century, India has a population of 1 billion

people. Although the annual growth rate has slowed from 2 to 1.8 percent, the base is so
broad that changes in population dynamics are not perceptible. The population may stabilize
by sometime between 2030 and 2040 if all sections of society support family planning
Page 1
wholeheartedly. The purchasing power of the middle class is growing (the middle-class
accounts for approximately 300 million people) and food habits are also changing.
The Indian economy is growing at the rate of 6 to 8 percent per annum. The
livestock industry in India is the second largest contributor to gross domestic product (GDP),
after agriculture, and accounts for 9 percent of the total. Consumption is likely to increase as
follows: per capita milk from 240 to 450 g per year; per capita eggs from 40 to 100 per year;
and per capita broiler meat from 1000 to 2000 g per year.
A major change is occurring in India on the economic front. The country has
adopted a model that lies midway between liberal and public sector production, but growth
has been affected by the poor performance of most of the public sector units, rising
government costs and fiscal deficit, and the economy has suffered. A process of liberalization
was set in motion by the government and has been implemented for the last eight to ten years.
This has caused India to open up and invite investment from multinationals, liberalize
imports, reduce government expenditure and remove public sector businesses. It also means
that the days of nationalization, unnecessary government controls and restrictions will soon
be over thanks to progress in the country's economy.
India has entered into an agreement with its trade partners under the world trade
organization (wto). The changes brought about by the liberalization process will be slow but
certain. The government is opening up imports in a phased manner, and it is expected that
this process will be completed by April 2003. In the meantime, about 930 items, including
agricultural products, will be open for import under open general license from April 2001,
making it possible to import dressed chicken, milk and milk products.
Various livestock industry associations have taken issue with such imports in an
attempt to protect their members. If the livestock industry is affected, the feed industry will
also be affected. The government of India has raised the tariff on all poultry and poultry
products from 35 percent to the wto boundary level of 100 percent. It therefore appears that
there will be a level playing field.
In view of the expected rise in per capita consumption of chicken meat, eggs
and milk, livestock production and productivity will grow. The dairy industry, which is
Page 2
cooperative-based, is growing with the increased capacities of milk processing units. The
population of cross-bred cattle and buffaloes is also growing. Milk is very popular in India.
The poultry industry is developing towards vertical integration and a few multinational
companies have already entered the Indian poultry business. Although the live bird market
currently accounts for about 90 percent of the total market, it is expected that the
consumption of dressed chicken will grow in the next five years, from the existing 10 percent
to 25 percent or more. This would mean establishing very hygienic and scientific processing
units. Cold chains, branded chicken, chicken cuts, etc. Will be introduced and, depending on
the success and consistent quality, consumer preference for dressed meat will grow.
The next decade will see significant changes in restructuring, mergers,

acquisitions, amalgamations, joint ventures, diversification, integration and efficient service
chains, e-commerce and use of the latest information technology in global tenders, trading,
export/import and other commercial activities. At the root of all these developments will be
the scientific development of feed manufacturing technology. The Indian feed industry will
increasingly use biotechnology, more scientific formulations, new molecules and natural and
herbal products to improve animal productivity. Indian agriculture will also use
biotechnology and genetically modified organisms (gmos) to support the feed industry, which
is entering a very exciting phase of growth for the next decade
Sector Feed Potential feed Estimated Estimated
consumption volume future annual future annual
(million required feed sector growth
tonnes) (million consumption (%)
tonnes) growth rate
(%)
Broiler 9.4 10.4 8^1 7-8
Layer 2-3 11.6 5-6^2 3-4
Cattle 7.5 67 6^3 4
Aqua 1 7 9^4 8
Table No: 1.1 Indian feed consumption and growth
Page 3
1.1 Market overview
The global feed additives market (henceforth, referred to as the market studied) was valued at
usd 31.74 billion in 2018, and it is expected to register a cagr of 4.6% during the forecast
period (2019-2024). Asia-pacific is projected to be the fastest-growing market. Economic
growth, industrialization of the livestock industry, rising farmers awareness, and government
support are the major factors for market attractiveness in this region.
Feed additives are essential for animal nutrition, as they improve the quality of feed, and
thereby improve animals’ performance and health. Industrialization of the livestock and meat
sector is an important factor driving the demand for feed additives across the world. Amino
acids, antibiotics, organic acids, and vitamins are the major segments, accounting for more
than 40% of the global feed additives market. The determined push from the EU for
alternatives to antibiotics has led to increased consumption of acidifiers and probiotics in
Europe. The poultry segment is the largest consumer in the market studied, and the present
trend of consolidation and backward integration of poultry processors is expected to maintain
a steady demand for additives during the forecast period.
Feed additives Market

70
60
50
40
64.6 66.6
30
57.4 61 61.3
52.9
20
10
0
2013 2014 2015 2016 2017 2018
Source: FAO, Mordor Intelligence

Chart No-1.1 Feed additives market: production volume in million metric ton, cattle meat,
global, (2013-2018)
Page 4
CHAPTER -2
ORGANIZATION PROFILE
Company Profile
Biotechnology is the use of living organisms to make or modify products, plants and
animals, or to develop micro-organisms for about the use of micro-organisms as catalytic
agents to produce useful materials or act in industrial processes.
Zeus biotech private limited invents and innovates biotechnologically derived life regulators.
Dr. Jay Prakash Nair, a microbiologist, with special interest in enzymes founded the
company as a partnership firm in the year 1979 to manufacture biotechnologically derived
animal feed supplements.
This private company was converted into a privately held corporate entity in the year
1991 and become a closely held public limited company in the year 2001.
Zeus biotech limited is based at the beautiful city of Mysore ,140 km away from Bangalore,
in the state of Karnataka in India.
Figure No: 2.1 Company Image
Page 5
Present
Two production unit in Mysore with a laboratory of international standards, Zeus

biotech and its associates produce all-natural world class nutritional and healthcare
supplement for poultry, dairy cattle, piggery, camels, horses, goats, sheep, aquaculture and
other animals.
The production units are gmp, iso 22000 & haccp certified to ensure that each and every step
of production is free from hazards. The quality control team ensures our products are with
international standards.
Zeus biotech does third party manufacturing also for various companies in the feed additive
business. The company has strong presence in various overseas markets like Malaysia,
Thailand, Vietnam, Nigeria & middle east, Bangladesh, Philippines, Bhutan, etc.
Zeus biotech produced the world's first feed specific synergistically acting enzyme
supplement polyzyme from a single substrate in the year 1991 by solid state fermentation
(ssf).
In the year 1994, Zeus biotech introduced the world's first broiler specific probiotics enzyme
feed supplement brozyme, produced by fermentation of five new generation bacillus culture
on a single substrate.
During the last decade, Zeus biotech and its associate companies have brought out many
innovative, 'all natural' feed supplements. They include double strain live yeast cultures
fermented on the herbal-grain mash, specifically for monogastric animals and ruminants;
herbo-mineral complexes for optimum egg production; organically bound micro-mineral
complexes for all animals; yeast nucleotides and phosphorylated yeast mann glucan
oligosaccharides.
Group companies
I. Jayson’s agritech pvt. Ltd.

Jayson’s agritech pvt. Ltd manufacture nutrition feed additives for
dairy & beef cattle. The range include ruminant specific yeast culture, organic trace
minerals complexes to enhance reproductive capacities, herbo minerals complexes to
optimize milk yield.
Page 6
II. Zymonutrients pvt. Ltd
Zymonutrients pvt. Ltd was set up to provide natural solutions for profitable
aquaculture production. Zymonutrients currently manufactures private label formulations for
importers in Malaysia and Vietnam. Recently, Zymonutrients
formulation of equine nutritional supplements as a substitute for imported products
currently manufactured are:
• Digimax – as intestinal digestive stimulant to prevent digestive disorders in
horses.
• Equition – direct feed microbial formulation composed of new generation
microbial spores to maintain the ceacal integrity and to improve ceacal fibre
digestion.
• Zymosac – the only hydrolysed yeast composed of hydrolysed amino acids,
glucomannan oligosaccharides and nucleotides to optimize growth in young
animals and to improve the functions of villi & liver cells.
• Chromisac-gtf – India’s first and the only gtf chromium in a niacinamide
complex for horses to improve energy utilization.
• Selenoscac-e – a combination of selenium proteinate fortified with natural
vitamin-e.
III. Zeus feed supplements pvt.ltd.
Zeus feed supplements pvt.ltd. Is engaged in the marketing of

innovative water soluble and liquid feed additives manufactured by Zeus biotech limited.
The product range include water soluble enzymes-probiotics complex, antibacterial cum-
stress inhibitors, organic acids-Phyto molecules complex, etc.
2.2 Nature of business
Manufacturer and exporter of animal feed supplements
2.3 Vision, Mission, Quality Profile and Food Safety Policy
2.3.1 Vision
Page 7
To be the leader in the feed supplement business and establish global presence
2.3.2 Mission
• To make livestock production profitable to the farmers by harnessing the power of
micro biotechnology in the field of animal health and nutrition.
• This mission helps to develop innovative and all-natural feed supplements. And
provide superior products to customers and maintain market leadership
2.3.3 Quality profile
• The customer satisfaction ensuring by the company Zeus biotech private limited by
giving customers need requirements by the utilizing the optimum resources and a
continual improvement of the system.
• The Zeus biotech private limited ensures hazard free area form the time of operation
they taking all controllable measures and taking effective preventive measure in
quality environment safety and health management and systematically recognizing the
problem and finally it will be solved.
2.3.4 Food safety policy

Zeus biotech private limited ensures safe product realization throughout the process
chain including post-delivery activities by controlling hazard and critical stages at all
point of operations.
Certification
• Iso 22000: 2005 certified by Intertek, accredited by ukas, United Kingdom.

• Iso 9001: 2008 certified by Intertek, accredited by ukas, United Kingdom.
• Haccp certified by Intertek.
• Gmp certification from the department of animal husbandry & dairying and ministry
of agriculture, government of India.
Page 8
2.4 Product profile
2.4.1 Poultry product
Polyzyme™
Figure No: 2.2

a feed specific synergistically acting multi-enzyme complex, produced by ssf technology.
• energises feed by 100 to 140 kilo calories/kg

• improves nutrient value of feed
• improves feed consumption rate (fcr)
Function
• Polyzyme maximizes feed digestibility by turning feed stuff into easily digestible and
absorbable form.
• Polyzyme helps generate energy from fibre,
• Polyzyme makes more nutrients-amino acids and trace minerals available to the bird.
Brozyme™
Figure No: 2.3
Guarantees heavier & healthier birds, and tender meat in lesser time with better fcr.
Page 9
Brozyme performance advantage
• 50 to 120 grams extra body weight in 42 days.

• Feed specific enzymes break down NSPS in feed ensuring more nutrient
bioavailability
• Liberates nsp bound nutrients and minerals - bird gets crucial ingredients for growth
Reduces viscosity of the gut caused by NSPS – improves intestinal absorption of nutrients
2.4.2 Cattle products

Rumiyeast
Figure No: 2.4

Ruminant specific double strain yeast culture to improve and sustain favourable ruminal
microbial population and ruminal health
benefits:
▪ Stabilizes rumen ph. (low rumen ph. decreases growth of ruminal bacteria).
▪ Reduces rumen ammonia levels (yeast cells utilize ammonia for survival and thereby reduce
ammonia levels in the rumen by 25%).
▪ Enhances ruminal favourable bacterial population.
▪ Enhances growth and weight gain in beef cattle.
▪ Improves cellulolytic enzymatic efficiency of rumen microbes.
▪ Increases milk production & protein, lactose and fat levels in the milk.
Lactomore
Page 10
Figure No: 2.5
Lactomore enhances the “milk let-down” action by helping to stimulate the production of
oxytocin.
Benefits:
▪ improves potential capacity of dairy animals for higher milk yield.

▪ high milk fat and optimum milk production.
▪ longer productive life.
▪ maintains healthy rumen and intestinal tract environment.
2.4.3 Piggery product

Niltox™
Figure No: 2.6
Curcuminoids, a natural antioxidant prevents oxidation of toxins, DNA adducts and cell
damage.
Page 11
Benefits:
• Improves immune response by improving antibody titter.

• Protects intestinal epithelium from parasites.
• Enhances response to vaccination.
• Reduces aflatoxin levels in finished pork products.
Minpork™
Figure No: 2.7
Minpork™ helps to increase lean meat content and reduce drip loss. Minpork™ also helps
to improve immunity and to reduce stress.
Benefits:
• increases lean meat content.

• reduces drip loss.
• improves colour.
• improves immunity.
• improves fertility in sows’
• reduces stress related problems.
2.4.4 Equine product
Page 12
Chromisac-gtf
Figure No: 2.8

Chromisac-gtf is designed to improve metabolic functions in horses. Chromium yeast -
niacinamide complex is more bioavailable than inorganic chromium and chromium chelates.
Actions:
▪ improves carbohydrates metabolism in growing horses and racing horses.

▪ optimizes performances in racing horses.
▪ reduces stress of racing horses.
▪ enhances immunity.
▪ reduces cortisol level in the plasma.
▪ helps to build better muscle structure & muscle mass.
▪ enhances utilization of high energy diets.
Selenosac-e
Figure No: 2.9

Selenosac-e protects horses from oxidation damages and prevents damages of cell
membranes.
Selenosac-e improves immunity against infections.
Page 13
Selenosac-e protects horses from exudative diathesis and muscular dystrophy.
2.4.5 Aquaculture product

Allicin-plus
Figure No: 2.10

The Ingredients present in allicin-plus is selected for their efficacy and non-toxic properties.
Advantages:
▪ reduced bacterial infections

▪ reduced toxic manifestations
▪ reduced environment contamination
▪ reduced feed input per kg of gain
▪ reduced expenses on medication
Digizye
Figure No: 2.11
Beneficial effects of digizyme:
Page 14
▪ Better feed utilization, therefore less feed waste; less nitrogen & phosphorus contamination in
the pond.
▪ Improved hygiene and health.
▪ Uniform growth.
▪ Improved productivity.
▪ Reduced incidences of diseases.
Competitors
Company Name Company Type City
Skanray Technologies Pvt Ltd Industry Top Mysore
Triphase Pharmaceuticals Pvt Ltd Industry Top Mysore
Bhagavan Pathology Laboratory Smes Mysore
Kaypeeyes Biotech Pvt Ltd Smes Mysore
Labland Biotech’s Pvt Ltd Smes Mysore
Millennium Chemi Pharma Mysore Pvt Ltd Smes Mysore
Regain Biotechnology Pvt Ltd Smes Mysore
Schevaran Laboratories Pvt Ltd. Smes Mysore
Vipragen Biosciences Pvt Ltd Smes Mysore
Table No: 2.1 Competitors
Page 15
WORK FLOW MODEL:
A work flow model is the sequential series of tasks and decisions that make up a business
process. Desiging a workflow model lets business users see how a process works and helps
them streamline and optimize it for best results and high efficiency..
Raw Material Feeding
Raw Material Weighing
Batch Grinding
Batch Mixing
Molasses Mixing
Palletizing
Bagging
Quality Check
Dispatch
Figure No: 2.12
Page 16
1. Raw material feeding: various raw materials to be taken for production are listed in
the raw material feeding report on a day to day basis and fed to the conveyors. The
materials fed is taken to the top floor through the conveyor.
2. Raw material weighing: the raw material is weighted in the weigh hopper as per the
formulate given by the chief nutritionist. For each recipe, separate formulae are
entered in the computer.
3. batch grinding: the batch which is weighed in the weigh hopper is taken for grinding
in hammer mills, where required sleeves are used to ensure adequate particle size for
the ground material.
4. Batch mixing: the material ground in the hammer mill is taken to the ribbon type
batch mixer for predetermined time to ensure homogeneous mixing. The minor
ingredients are directly added to the mixer.
5. Molasses mixing: the required molasses added to the batch and mixed in molasses
mixer.
6. Palletizing: the food that is mixed with the molasses is passed through the pellet mill
feeder conditioner where required quantity of steam is added. It is then passed through
the pellet mill where pellet is produced. The hot pellets are cooled in cooler and then
bagged.
7. Bagging: after completion of production, bagging is done and appropriate
identification is done with respect to the date and shift of production.
8. Identification is done with respect to the date and shift of production.
Page 17
2.5 Ownership pattern
Managing director Mr. Abhilash Nair
Director (marketing department) Mr. Jose Jinesh
Director (finance & administration Mr. Vinod pal lathery

department)
Director (material management) Mr. Silambu Selvam
Table No:2.2 Ownership pattern
Percentage of the share holding pattern
Category Sub category No of % of holding

securities
held
Promoter’s Indian promoter’s 66.12

holding 4094175
Foreign promoter’s 00
000
Sub total 66.12

4094175
Institutional Mutual fund and uti 13.34

investors 826062
Banks, insurance co.’s, central/state 14.49

government and non-government 896926
institution
Sub total 27.83
Page 18
1722988
Other Private corporate bodies 6.05

374822
Any other 00
00
Sub total 6.05

374822
Grand total 100

6191985
Table No: 2.3 Share Holding Pattern
2.6 Future growth and prospects

• The Zeus biotech private limited expecting every year 15% of growth and constructed
new laboratory facility of 15,000 sq. Feet.
• they keep on improving existing products and they are strengthening of marketing
team to achieve the goal of 15% of growth.
• High quality of product.
• Profit maximization.
Page 19
CHAPTER -3
McKINSEY’S 7S FRAMEWORK AND PORTER’S FIVE

FORCE MODEL WITH SPECIAL REFERNCE TO
ZEUS BIOTECH PRIVATE LIMITED
3.1 McKensy’s 7’s framework
Application of Mckensy‟ s 7s modal at Zeus biotech pvt. Ltd. The model starts on the
premise that an organization is no just structure, but consists of 7 elements with a complex
relationship between them.
The 7-s model is a frame work for analysing the organization and their effectiveness as a
whole. It first appeared in the “the art of Japanese management” by Richard pascal and
Anthony ethos in 1981.the 7-s model was born at a meeting of the four authors in 1978.
Structure
Strategy Systems
Shared
Valued
Skills Style
Staff
Figure No: 3.1 McKenny’s 7’s framework
Page 20
➢ STRUCTURE:
Organization structure refers to the relatively more durable organizational

arrangements and relationship. Zeus biotech pvt. Ltd., both the formal and informal type of
organizations is following.
Managing Director
Director-Marketing Director- Director-

Material
Finance
Management
AGM- Zonal Regional Purchase / Manager-

Sales Sales Sales Dispatch Accounts
Manager Managers Assistants
Area Sales Accounts

Assistants
Managers
Area
Sales
Officers
Manager- Manager- Manager- Manager- Manager-
R&D Quality Factory Maintenance HR
Assurance
Microbiologists / Microbiologists Supervisors Maintenance
Biotechnologists Supervisors
Lab Assistants Workers

Lab Assistants
Figure No: 3.2 Organizational Structure
➢ SYSTEM:
System refers to the procedure and process such as the information process, budgeting
and the control process. Zeus biotech as a wide scope and covers almost all areas of human
resources; mainly it covers the following areas:
Page 21
• Environment management system:

Zeus biotech recognizes the impact that their business has the environment and takes the
responsibilities for maintaining harmony with nature. Jesus biotech are the first biotech
company in Mysore to receive„ ISO 9001” certification by Intertek, accredited by ukas,
United Kingdom in 2005.
• Internal control system:

the philosophy of the company with regard to adequacy of internal control system has been
the formulation of effective systems & their strict implementation to ensure that assets &
interests of the company are safeguarded, checks & balances are put in place to determine the
accuracy & reliability of financial data.
Rules and regulation of the employees in Zeus biotech company
• Each employee must act in accordance with the company’s policies, order, rules,
regulation, guidelines etc applicable from time to time.
• The duty must perform in good faith and a brief reporting of the work done in the
entire day must be given to the head office.
• Proper registers must be maintained for easy tracking and recordkeeping.
• No employee shall drive a company’s vehicle or operate any equipment while under
the influence of alcohol.
• You are required to be at your appointed work place and ready to begin work at the
appointed starting time. Irregular attendance or tardiness will not be tolerated and
may result in termination
• Employees who will be late or absent from work must inform their supervisor at least
two (2) hours prior to normal starting time.
• Designated break timers are assigned to have meals.
• Under no circumstances should employees leave the assigned work area early
without express permission from a supervisor.
• An increment based on individual performance shall be given every year.
• Employees who work late or on overtime must ensure that all lights, air-conditions
and equipment’s are shut off when they leave the work place.
Technical Training
Page 22
• Developed customized technical pharmaceutical training
• Developed and delivered customized MS Office training for global offices for 200 users
• Developed and delivered custom documentation and training
• Developed and delivered enterprise-wide system administration training
• Delivered sales force automation training 50 managers and field sales representatives
• Provided project management, assessments, development and delivery of Microsoft Office

to 400 sales representatives
Recruitment
Recruitment is the process of searching for prospective employees and stimulating them to
apply for jobs in the organization. This is made on the base of personal interview. Only
qualified candidates are selected. Final selection is done by the head office.
Promotion
Advancement within an organization is ordinarily labelled as promotion. It

refers to the advancement on an employee to a better job. Promotion is a mean of filling up
vacancies which occur in any organization from time to time. Promotion is given on the basis
of:
• Seniority
• Performance
• Additional Qualification
There is an understanding between the workers and the management that

promotions will be made on the basis of ability and seniority.
➢ STRATEGY
The main strategy is to ensure maximum utilization of available resources. For this purpose,
the company believes in mainly prompting from within the organization and there by
encourages its people to strive for higher management stability.
Waste elimination strategy
The company insists on education on continuous basis for
Page 23
other workers and the staff. Total productive maintenance (tpm) and quality circle is
practiced from the lowest level, as a management seeks continues improvement from workers
in every record. There exist clarity of vision and goal with in the company as a result of
which the productive efficiency of the company goes up energy conversation strategy.
The company maintained its focus on energy on energy consumption in face of rising energy
costs by continual investment in latest energy efficient system.
Goals
• To achieve a minimum compound growth rates on sales turnover.

• To promote sales turnover.
• To provide for the optimum use of technological innovation.
• To enhance productivity.
➢ SKILL
A skill is the ability knowledge, understanding and judgment to accomplish a task. Skills may
be defined as the company does best, the distinctive capabilities and competencies that reside
in the organization. The skills differ with respect to performance of the skill differ with the
performance they require a postgraduate with specification in human resource management.
Technical skills:
A technical skill refers to the ability and knowledge in using the equipment, technique and
procedures involved in performing specific tasks.
Human skills:
Human skills consist of the ability to work effectively with other people both as individual
and as member of a group, at Zeus biotech company.
Conceptual skill:
Conceptual skills allow a manager to visualize the entire organisation and work with ideas
and the relationship between abstract concept.
➢ STYLE:
The style in an organization, according to mc Kinney‟ s frame work refers to the “reporting
relationship” between the superiors and the subordinates. It also conveys the flows of
communication between them. Autocratic leadership style was followed by the company.
Page 24
➢ STAFF
The person in an organization is called staff. Here it is very useful to think not about
individual personality but corporate demographics. An analysis of the corporate
demographics of vtl reveals that most of the worker and staff belong to the 30-40 age groups.
Duties and responsibility of production department
• Identifying inputs
• Scheduling production
• Minimizing production cost
• Ensuring product quality
Duties and responsibility of marketing department
• Setting marketing strategy

• Importance of market research
• Internal or external product development
• Communication and promotional materials
Duties and responsibility of financial department
• Cost control
• Billing and credit control
• Investment appraisal
• Handling tax issues
Human resource
The company firmly believes that talented & engaged are the critical differentiators &
provide competitive advantage for sustaining & growing the business in the intensified spiral
of global competition. As such, the company continues its focus on high performance, talent
retention, employee engagement & customer first as the corner of its hr strategies.
➢ SHARED VALUES
Page 25
Zeus biotech pvt. Ltd initiative to do social project such activities like literacy program for
village people. Thus, some of the values that are shared by the both employees and the
management at Zeus biotech pvt.ltd.as follows:
Zeus biotech-a socially responsible corporate citizen
Zeus biotech as a corporate citizen has consistently to improve the quality of life of people in
around its area of operations & society at large. During the year under review,
3.2 Porter five force analysis
Porter five forces analysis is a framework that attempts to analyse the level of competition
within an industry and business strategy development. It draws upon industrial organization
(io) economics to derive five forces that determine the competitive intensity and therefore
attractiveness of an industry.
Bargaining
Power of
Suppliers
Threat of
Rivalry inside Threat of
New
the Industry Substitutes
Entrants
Bargaining
Power of
Customers
Figure No: 3.3 Porter five force analysis
Page 26
Attractiveness in this context refers to the overall industry profit ability. An “unattractive”
industry is one in which the combination of these five forces acts to drive down overall
profitability. A very unattractive industry would be one approaching “pure competition”, in
which available profits for all firms are driven to normal profit. This analysis is associated
with its principal innovator Michael. Porter of Harvard university.
Porter referred to these forces as the micro environment, to contrast it with the more
general term macro environment. They consist of those forces close to a company that affect
its ability to serve its customers and make a profit
➢ Threat of new entrants:
profitable markets that yield high returns will attract new firms. This results in many new
entrants, which eventually will decrease profitability for all firms in the industry. Unless the
entry of new firms can be blocked by incumbents (which in business refers to the largest
company in a certain industry, for instance, in telecommunications, the traditional phone
company, typically called the “incumbent operator”), the abnormal profit rate will trend
towards zero (perfect competition).
Competitors for Zeus biotech are
• Skanray Technologies Pvt Ltd
• Triphase Pharmaceuticals Pvt Ltd
• Bhagavan Pathology Laboratory
• Kaypeeyes Biotech Pvt Ltd
• Labland Biotech’s Pvt Ltd
• Millennium Chemi Pharma Mysore Pvt Ltd
• Regain Biotechnology Pvt Ltd
• Schevaran Laboratories Pvt Ltd.
• Vipragen Biosciences Pvt Ltd
➢ Threat of substitute:
Page 27
products or services the existence of products outside of the real of the common product
boundaries increases the propensity of customers to switch to alternatives. For example, tap
water might be considered a substitute for coke, whereas Pepsi is a competitor’s similar
product. There is no magic, undiscovered feed ingredient that cuts feed costs dramatically
during times when maize and soybean prices increase dramatically.
➢ Bargaining power of customers:
the bargaining power of customers is also described as the market of outputs: the ability of
customers to put the firm under pressure, which also affects the customer’s sensitivity to price
changes. Firms can take measures to reduce buyer power, such as implementing a loyalty
program. The buyer power is high if the buyer has many alternatives. The buyer power is low
if they act independently e.g. If a large number of customers will act with each other and ask
to make prices low the company have no other choice because of large number of customers
pressure.
➢ Bargaining power of suppliers

the bargaining power of suppliers is also described as the market of inputs. Supplier so
raw materials, components, labour, and services (such as expertise) to the firm can be a
source of power over the firm when there are few substitutes.
Potential factors are:
• Supplier switching costs relative to firm switching costs

• Degree of differentiation of inputs
➢ Intensity of competitive rivalry

For most industries the intensity of competitive rivalry is the major determinant of the
competitiveness of the industry.
Potential factors:
• Sustainable competitive advantage through innovation

• Competition between online and offline companies
• Level of advertising expense
• Powerful competitive strategy
• Firm concentration ratio
• Degree of transparency
Page 28
CHAPTER -4
SWOT ANALYSIS
Swot analysis is a strategic planning technique used to help a person or organisation identify
strengths, weaknesses, opportunities, and threats related to business competition. Strengths
and weakness are frequently internally-related, while opportunities and threats commonly
focus on the external environment.
➢ STRENGTHS:
Strength in SWOT analysis are the attributes within an organization that are considered to be
necessary for the ultimate success of a project. Strengths are resources and capabilities that
can be used for competitive advantages.
The Zeus biotech private limited’s strength are,

• Well known for its quality.
• Health environment to the employee.
• Excellence brand image.
• Team of employee.
• Excellence distribution network.
Page 29
➢ WEAKNESS:
Weaknesses include factors such as an abundance of rivalry between departments, a weak

internal communication system, lack of funding and an inadequate amount of materials.
Weakness can derail a project it even begins.
Weakness of Zeus biotech private limited are
• Lack of technology up gradation

• Transportation problem
• Connectivity issue(communication problem, signals, internet)
• Lack of poor infrastructure facilities
• The person nutritional pvt ltd company is out of the city
• Similar products produced by many companies
➢ OPPORTUNITIES:
Opportunities are classified as external elements tht might be helpful in achieving the goals
set for the project. These factors could involve vendors who wish to work with the company
to help achieve success, the positive perception of the company by the general public, and
market condition that could make the project describe to the segment of the market.
Opportunities of Zeus biotech private limited are
• Coordination of production
• Entry of new innovative products
• Skilled employees
➢ THREATS:
These external factors could gravely affect the success of the project or business venture. The
possible threats that are critical to any SWOT analysis include a negative public image, no
readymade market for the lack of vendors who are able to supply raw materials for the
project.
Threats of Zeus biotech private limited are
• Fluctuation in the raw material prices

• Entry of new competitors
• Credit system in the market
• Exchange rate fluctuation
•
Page 30
CHAPTER -5
ANALYSIS OF FINANCIAL STATEMENTS

Balance sheet as on 31st march (Rs.in Crores)
PARTICULAR NO 2017-18 2018-19
EQUITY AND LIABILITIES
1. Shareholders fund
Share Capital 11.34 11.34
Reserves and Surplus 342.83 407.15
354.17 418.49
2. Non-Current Liabilities
Long-Term Borrowings 375.80 409.32
Deffed Tax Liabilities 107.03 147.72
Other Long-Term Liabilities 76.64 75.24
Long Term Provision 3.66 4.71
563.13 636.99
3. Current Liabilities
Short-Term Borrowings 218.70 373.64
Trade Payable 207.60 227.74
Other Current Liabilities 154.16 161.91
Shot-Term Provision 90.62 1.63
671.08 764.92
TOTAL EQUITY AND LIABILITIES 1588.38 1820.40
Page 31
ASSETS
1. Non-Current Assets
• Fixed Assets
Tangible Assets 831.85 825.14
Intangible Assets 00 00
Capital Work In progress 22.23 32.81
Non-current Investment 19.14 122.54
Long-Term Loans and Advance 52.01 10.58
Other Non-Current Assets 18.95 77.59
944.18 1068.66
2. Current Assets
Current Investment 3.75 00
Inventories 184.92 232.70
Trade Receivables 302.62 368.40
Cash and Bank balances 15.61 16.83
Short-Term Loans and Advance 134.75 17.50
Other Current Assets 2.55 116.31
644.20 751.74
TOTAL ASSETS 1588.38 1820.40
TABLE NO-5.1
In the above balance sheet observed that found the current ratio, quick ratio, debt equity ratio,
Fixed Assets Turnover Ratio and proprietary ratio are showing the financial position of the
company.
Page 32
Liquidity Ratio: It gives idea about company’s ability to convert its assets into cash and pay
its current liabilities with the cash whenever required.
Year Current Ratio=Current Assets /Current Current Ratio

Liabilities
2017-18 644.20/671.08 0.95:1
2018-19 751.74/764.92 0.98:1
Year Quick Ratio=Quick Assets /Current Quick Ratio

Liabilities
2017-18 671.08/1588.38 0.42:1
2018-19 764.92/1820.40 0.42:1
Table No: 5.2 Liquidity Ratio
Interpretation:
Current ratio of each year not equal or not near to the Rule of thumb 2:1 Current liabilities
over the current liabilities. So, it is indicating company is liquidity position not good or not
satisfactory and shall not be able to pay its current liabilities.
Quick ratio of the company is not satisfactory or not good short-term financial strength and
solvency of the company because liquidity ratio not reaches the rule of 1:1.
Solvency Ratio: A solvency ratio measures the extent to which assets cover commitments for
future payments, the liabilities. The solvency ratio of an insurance company is size of its
capital relative to all risks it has taken.
Year Debt-equity Ratio=Debt /Worth Equity Debt-equity

Ratio
2017-18 375.80/354.17 1.06:1
2018-19 409.32/418.49 0.97:1
Page 33
Year Proprietary Ratio=Stake Holder’s Equity Proprietary

/Total Assets Ratio
2017-18 354.17/1588.38 0.22:1
2018-19 418.49/1820.40 0.23:1
Year Fixed Assets Ratio= Net Sales /Average Fixed Fixed Assets
Assets Ratio
2017-18 1652.68/944.18 1.75 Times
2018-19 1733.67/1068.66 1.62 Times
Table No: 5.3 Solvency Ratio
Interpretation:
Debt equity ratio of the company in the year 2017-18 and 2018-19 is satisfactory because
debt is high to the equity or funds. It indicates company has been aggressive in financing its
growth with debt.
Proprietary ratio of the company it indicating decrease every year owner’s capital to total
capital (Total Assets) of the company so improve the long-term solvency position of the
company.
Fixed Assets turnover ratio of the company in the year 2017-18 is 1.75 and in the year 2018-
19 is1.62. It is Decreased compare to 2017-18.
Page 34
Consolidated Of P&L A/C for The Year Ended 31st March

SL NO PARTICULAR 2017-18 2018-19 Increase or Decrease Percentage
Revenue from
1 1845.99 1901.74
operations 55.75 3.02%
Revenue from
2 1652.68 1733.67
operations (net) 80.99 4.90%
Operating profit
3 0 0
(PBIDT) 0 0
Net profit / (loss) for
the period (before tax
4 193.25 168.07
but after Exceptional
items) -25.18 -13.02%
the period (before tax
5 121.39 164.88
and Exceptional
items) 43.49 35.82%
the period (After tax
6 133.12 114.2
and Exceptional
items) -18.92 -14.21%
Total comprehensive
income for the period
[comprising profit
7 /(loss) for the period 82.42 116.83
(after tax) and other
comprehensive
income (after tax)] 34.41 41.74%
8 Equity share capital 11.34 11.34 0 0
Other equity
excluding revaluation
9 reserve as shown in 338.91 426.52
audited balance sheet
of previous year 87.61 25.85%
Earnings per share

10 (of Rs 2 each) 23.48 20.14
basic/diluted
Table-5.4
In the above Income Statement observed that found the Operating Profit Ratio, Net Profit
Ratio, return on Equity and return on Employed are showing Profit and Loss of the company.
Page 35
Profitability Ratio: Profitability ratio is used to evaluate the company’s ability to generate
income as compared to its expenses and other cost associated with the generation of income
during a particular period. This ratio represents the final result of the company.
Year Operating Profit Ratio= Operating Profit/ Net Operating

Sales Profit Ratio
2017-18 193.25/1652.68 11.69%
2018-19 168..07/1733.67 9.69%
Year Net Profit Ratio= Net Income/ sales Net Profit

Ratio
2017-18 133.12/1652.68 8.05%
2018-19 144.20/1733.67 8.31%
Table No: 5.5 Profitability Ratio

Interpretation:
Operating Profit ratio of the company is decreased from11.69% to 9.69% in the year
2017-18 to 2018-19
Net Profit ratio of the company is increased from 8.05% to 8.31% in the year 2017-18
to 2018-19. Revenue is increased and profit also increased
Return Ratio: The return on assets ratio measures how effectively a company can earn a
return on its investment in assets.
Year Return on Capital Employed=Operating Return on

Profit/Employed Capital Capital
Employed
2017-18 193.25/917.30 21.07%
2018-19 168.07/1055.48 15.92%
Page 36
Year Return on Equity=Net Income/ Stake Return on

Holder’s Equity Equity
2017-18 133.12/354.17 37.59%
2018-19 114.20/418.49 34.46%
Table No: 5.6 Return Ratio
Interpretation:
In return on capital employed the high the ratio, the better it is, as it shows robust overall
profitability. But Zeus biotech pvt. Ltd, it did not improve its performance compare to 2018
to 2019 it is decreasing so, it must concentration on company performance.
In return on equity ratio is helpful for making inter-firm comparisons, it can also be used to
comparing performance over a period of time. But Zeus biotech pvt. Ltd, compare to 2017-18
in 2018-19 the return rate to shareholders is less the company need to improve its
performance for increase the return.
Page 37
CHAPTER -6
LEARNING EXPERIENCE
My learning experience in the company was very pleasant. The response and support I got
from the management and staffs were appreciable. This training helped me to know
practicalities. I learned about management from practical perspective and I learnt about
organizations to how it works in management aspects and the policies and procedures totally
it was a highly useful training for me in the company.
During the first week. It was new experience entering into the organization. The training was
very informative and useful as it enables us to have a corporate look over the functioning of
each and every department of the company apart from the theoretical knowledge.
During the month of my internship for the period of one month at ZEUS BIOTECH PVT.
LIMITED,
• I have understood how the industry functioning.

• I have observed and understand the professional environment which has helped me to
improve my knowledge and skills.
• Since, the working experience in the purchase department has impart ed me with the
knowledge about its working and functions.
In company they give the information about all the plant sand they give a chance to attend an
employee meeting and GST class, do a work in the finance and HR department.
To conclude, this project has given me practical exposure in the study of organization. It was
a great experience working. Where I learnt many things about the functioning of the
organization in accordance with the present market trends. The main purpose of the
organization study is to make student acquainted with the practical knowledge the overall
functioning of the organization.
Page 38
Conclusion
The internship opportunity provided by Zeus biotech pvt.ltd, Mysuru has helped me fulfil not
only my course objective but also enabled me to learn about the Organization. The exposure I
received during the course of my internship at Zeus biotech pvt.ltd, Mysuru has enabled me
to understand the corporate world even better. The skills I’ve learned during this period will
definitely help in my future endeavours. All in all, can say that it was a good experience
interning at Zeus biotech pvt.ltd, Mysuru.
I am thankful to the management forgiving me this opportunity to be a part of the Zeus

biotech pvt.ltd for a short while and will forever remember the experience.
Page 39
Bibliography/ Reference
• www.zeusindia.net
• www.moneycontrol.com
• www.learninglight.com
• www.niir.org
• Zeus biotech pvt. Ltd, annual report
• Kotler Phillip, ‘Marketing management’ Eleventh edition,
prentice Hall of India Pvt ltd. 2005
• https://corporatefinanceinstitute.com
Page 40

Zeus Report SACHIN K P

Uploaded by

Copyright:

Available Formats

Zeus Report SACHIN K P

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Zeus Report SACHIN K P

Uploaded by

Copyright:

Available Formats

An Organization study On Zeus Biotech Private Limited, Mysuru

INTRODUCTION ABOUT THE INDUSTRY

1.1 The future of the Indian feed industry

At the beginning of the twenty-first century, India has a population of 1 billion

The next decade will see significant changes in restructuring, mergers,

1.1 Market overview

Feed additives Market

Source: FAO, Mordor Intelligence

Figure No: 2.1 Company Image

Two production unit in Mysore with a laboratory of international standards, Zeus

I. Jayson’s agritech pvt. Ltd.

II. Zymonutrients pvt. Ltd

Zeus feed supplements pvt.ltd. Is engaged in the marketing of

2.2 Nature of business

Manufacturer and exporter of animal feed supplements

2.3 Vision, Mission, Quality Profile and Food Safety Policy

2.3.4 Food safety policy

• Iso 22000: 2005 certified by Intertek, accredited by ukas, United Kingdom.

2.4 Product profile

2.4.1 Poultry product

Figure No: 2.2

• energises feed by 100 to 140 kilo calories/kg

Figure No: 2.3

Brozyme performance advantage

• 50 to 120 grams extra body weight in 42 days.

2.4.2 Cattle products

Figure No: 2.4

Figure No: 2.5

▪ improves potential capacity of dairy animals for higher milk yield.

2.4.3 Piggery product

Figure No: 2.6

• Improves immune response by improving antibody titter.

Figure No: 2.7

• increases lean meat content.

2.4.4 Equine product

Figure No: 2.8

▪ improves carbohydrates metabolism in growing horses and racing horses.

Figure No: 2.9

Selenosac-e protects horses from exudative diathesis and muscular dystrophy.

2.4.5 Aquaculture product

Figure No: 2.10

▪ reduced bacterial infections

Figure No: 2.11

Beneficial effects of digizyme:

Company Name Company Type City

Skanray Technologies Pvt Ltd Industry Top Mysore

Triphase Pharmaceuticals Pvt Ltd Industry Top Mysore

Bhagavan Pathology Laboratory Smes Mysore

Kaypeeyes Biotech Pvt Ltd Smes Mysore

Labland Biotech’s Pvt Ltd Smes Mysore

Millennium Chemi Pharma Mysore Pvt Ltd Smes Mysore

Regain Biotechnology Pvt Ltd Smes Mysore

Schevaran Laboratories Pvt Ltd. Smes Mysore

Vipragen Biosciences Pvt Ltd Smes Mysore

Table No: 2.1 Competitors

WORK FLOW MODEL:

Raw Material Feeding

Raw Material Weighing